1/ Senator Bill Frist, MD ($TDOC Board Member for 7 years) on CEO Jason Gorevic:
“One thing that obviously impressed me about your leadership is your ability to say where you’re going based on, as you've said, a plan from 7 years ago - the pyramid that you’ve always presented...
2/ ...that this is where we’re going to be someday. Everybody presents that, but you made it real block by block. I still have those initial slides of your presentation. As you’ve said, none of this is new in your mind.”
Link >>
3/ Am confident in $TDOC. Despite recent events: (i) MDLive acquired by $CI in Feb '21, and (ii) Dr. on Demand merging with Grand Rounds in Mar '21, and (iii) $AMZN Care offering services to employers across the nation by summer '21...
4/ ... Important to remember that $CI has been a long-term investor in MDLive. Since launching in '09, MDLive has brought in $200mm in funding w/ $CI's venture arm as a key investor. $TDOC has relationships w/ tons of other large payors $CVS's Aetna, $UNH, BCBS nationwide ...
5/... DoD's merger w/ Grand Rounds is yet another confirmation of today's opportunities in healthcare. Exposes current scrambling within the industry as everybody wants to gain solid footing in capabilities. Expect more consolidation / hybrid models / virtual primary care ...
6/... $TDOC was first to step forward, whereas the others have just started to move. $TDOC has first-mover advantage / experience in tuck-in strategy. Better Help acquired Jan '15 for $4.3mm; visit growth now >100x. $TDOC offerings create snowball effect. InTouch / Livongo...
7/... drives continuum of care and Primary360, while others have yet to even prove integration efforts. Per video above, Gorevic's been with $TDOC for 12 years, struggled for 5 months to raise $TDOC's Series C, lived through ups and downs re: regulation, customer acceptance...
8/ but he has executed over and over, growing sales from $4mm his first year on the job to $1.1Bn LFY.
And of course, re: $AMZN, we all knew they would commercialize their Care initiative one day. Nothing's new. $AMZN has also lost before on more than one occasion.
- "Key Geographies" Supply-Driven TAM
- U.S. Supply-Driven TAM
- Demand for Organ Transplants (Lung/Heart/Liver)
- Larger donor list --> larger recipient list
- Quick revenue sizing based on current demand
- More positive catalysts
1/ Company-provided TAM from $TMDX's 10K of $8.02Bn for lung, heart and liver.
This is supply-driven i.e., sizing opp by unlocking utilization of previously unused organs.
"Key Geographies" per $TMDX include US, Canada, EU and Australia.
2/ We extrapolate $TMDX's TAM for U.S. by applying utilization assumptions from above to Company-provided U.S. figures.
We get U.S. TAM of approx $3.65Bn.
Important to know b/c a successful FDA panel will first benefit U.S. commercial efforts, then trickle over to int'l after.